Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The substrate of increased cortical FA in MS: A 7T post-mortem MRI and histopathology study.
Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice.
Is electroconvulsive therapy safe in multiple sclerosis?
New discovery rarely runs smooth: an update on progranulin/TNFR interactions.
Effectiveness of multi-disciplinary rehabilitation for patients with Neuromyelitis Optica.
The mechanisms of neurotoxicity and the selective vulnerability of nervous system sites.
Chronic Peripheral Inflammation, Hippocampal Neurogenesis, and Behavior.
Cost-Utility of Fingolimod Compared With Dimethyl Fumarate (Dmf) In Highly Active Relapsing Remitting Multiple Sclerosis (Rrms) In England: Comparison of A Markov and Discrete Event Simulation Model.
Dendritic cells in brain diseases.
Are cognitive interventions for Multiple Sclerosis effective and feasible?
Neuromyelitis Optica IgG Causes Placental Inflammation and Fetal Death.
Frequency, characteristics and consequences of falls in multiple sclerosis: findings from a cohort study.
Restriction genes for retroviruses influence the risk of multiple sclerosis.
High Fat Diet Exacerbates Neuroinflammation in an Animal Model of Multiple Sclerosis by Activation of the Renin Angiotensin System.
Caregiving in multiple sclerosis.
The NLR family member, NLRX1, mediates protection against experimental autoimmune encephalomyelitis and represses macrophage/microglial-induced inflammation.
Diffusion tensor MRI alterations of subcortical deep gray matter in clinically isolated syndrome.
Abnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis.
Alterations in Immune Cells and Mediators in the Brain: It's Not Always Neuroinflammation!
Increased frequency and severity of restless legs syndrome in patients with neuromyelitis optica spectrum disorder.
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis.
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study.
Fingolimod for relapsing-remitting multiple sclerosis.
The disruption of mitochondrial axonal transport is an early event in neuroinflammation.
Teriflunomide: A Once-Daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis.

Pages